We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Experimental Physicists Find Clues into How Radiotherapy Kills Cancer Cells

By LabMedica International staff writers
Posted on 29 Oct 2014
Print article
A new discovery in experimental physics has implications for a better determination of the process in which radiotherapy destroys cancer cells.

Dr. Jason Greenwood from Queen’s University Belfast (Ireland) Center for Plasma Physics collaborated with scientists from Italy and Spain on the work on electrons, and published this groundbreaking finding October 17, 2014, in the international journal Science. By means of some of the shortest laser pulses, the researchers employed strobe lighting to monitor the ultra-fast movement of the electrons within a nanometer-sized molecule of amino acid. The resulting oscillations—lasting for 4,300 attoseconds—amount to the fastest process ever observed in a biologic structure.

Dr. Greenwood said, “Explaining how electrons move on the nanoscale is crucial for the understanding of a range of processes in matter as it is this charge which initiates many biological, chemical, and electrical processes. For instance, the charge produced from the interaction of ionizing radiation with DNA and its subsequent ultra-fast movement can lead to damage of the DNA and cell death which is exploited in radiotherapy to treat cancer. This knowledge is therefore important for understanding the action of radiotherapy beams in cancer treatment. Being able to describe how light interacts with electrons on these timescales could also lead to improvements in how light is converted into electricity in solar cells or faster microprocessors, which use light rather than electrical signals for switching transistors.”

The research was performed by Queen’s School of Mathematics and Physics in collaboration with the Politecnico Milano (Italy), the Universidad Autónoma of Madrid (Spain), University of Trieste (Italy), and Institute of Photonics and Nanotechnologies IFN-CNR (Padua, Italy).

Dr. Greenwood concluded, “This research will hopefully open up the emerging field of attosecond science which seeks to understand how ultrafast electrons play a key role in chemistry, biology and nanotechnology. This is very early research but this new field of ultrafast light-induced electronics is likely to have an impact in biology, chemistry and materials in the next five to 10 years. Practical applications down the line may include improvements in cancer radiotherapy, highly efficient solar cells, and much faster computer processors.”

Related Links:

Queen’s University Belfast
Politecnico Milano 
Universidad Autónoma of Madrid 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.